4-(5-Amino-pyrazol-1-yl)benzenesulfonamide derivatives as novel multi-target anti-inflammatory agents endowed with inhibitory activity against COX-2, 5-LOX and carbonic anhydrase: Design, synthesis, and biological assessments
Published 2023 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
4-(5-Amino-pyrazol-1-yl)benzenesulfonamide derivatives as novel multi-target anti-inflammatory agents endowed with inhibitory activity against COX-2, 5-LOX and carbonic anhydrase: Design, synthesis, and biological assessments
Authors
Keywords
-
Journal
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
Volume -, Issue -, Pages 115180
Publisher
Elsevier BV
Online
2023-02-03
DOI
10.1016/j.ejmech.2023.115180
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Fluorochrome Selection for Imaging Intraoperative Ovarian Cancer Probes
- (2022) Maria Grazia Perrone et al. Pharmaceuticals
- Development of 4-((3-oxo-3-phenylpropyl)amino)benzenesulfonamide derivatives utilizing tail/dual-tail approaches as novel carbonic anhydrase inhibitors
- (2022) Mostafa M. Elbadawi et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Design and synthesis of benzothiazole-based SLC-0111 analogues as new inhibitors for the cancer-associated carbonic anhydrase isoforms IX and XII
- (2022) Tarfah Al-Warhi et al. JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY
- Design, synthesis, and molecular docking of novel pyrazole-chalcone analogs of lonazolac as 5-LOX, iNOS and tubulin polymerization inhibitors with potential anticancer and anti-inflammatory activities
- (2022) Asmaa H.H. Ahmed et al. BIOORGANIC CHEMISTRY
- Development of novel benzofuran-based SLC-0111 analogs as selective cancer-associated carbonic anhydrase isoform IX inhibitors
- (2021) Moataz Shaldam et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- OPLS4: Improving Force Field Accuracy on Challenging Regimes of Chemical Space
- (2021) Chao Lu et al. Journal of Chemical Theory and Computation
- Deciphering the key heterocyclic scaffolds in targeting microtubules, kinases and carbonic anhydrases for cancer drug development
- (2021) Mudasir Nabi Peerzada et al. PHARMACOLOGY & THERAPEUTICS
- Synthetically-tailored and nature-derived dual COX-2/5-LOX inhibitors: Structural aspects and SAR
- (2021) Minakshi A. Meshram et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Carbonic anhydrase inhibitors: an update on experimental agents for the treatment and imaging of hypoxic tumors
- (2021) Claudiu T. Supuran EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Synthesis and biological screening of some novel 6‐substituted 2‐alkylpyridazin‐3(2 H )‐ones as anti‐inflammatory and analgesic agents
- (2020) Yasser M. Loksha et al. ARCHIV DER PHARMAZIE
- Inclusion of a 5-fluorouracil moiety in nitrogenous bases derivatives as human carbonic anhydrase IX and XII inhibitors produced a targeted action against MDA-MB-231 and T47D breast cancer cells
- (2020) Andrea Petreni et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Discovery of Potent Dual-Tailed Benzenesulfonamide Inhibitors of Human Carbonic Anhydrases Implicated in Glaucoma and in Vivo Profiling of Their Intraocular Pressure-Lowering Action
- (2020) Mohamed Fares et al. JOURNAL OF MEDICINAL CHEMISTRY
- Benzylaminoethyureido-Tailed Benzenesulfonamides: Design, Synthesis, Kinetic and X-ray Investigations on Human Carbonic Anhydrases
- (2020) Majid Ali et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Structural and mechanistic insights into 5-lipoxygenase inhibition by natural products
- (2020) Nathaniel C. Gilbert et al. Nature Chemical Biology
- Benzofuran-Based Carboxylic Acids as Carbonic Anhydrase Inhibitors and Antiproliferative Agents against Breast Cancer
- (2020) Wagdy M. Eldehna et al. ACS Medicinal Chemistry Letters
- Benzoxaboroles: New Potent Inhibitors of the Carbonic Anhydrases of the Pathogenic Bacterium Vibrio cholerae
- (2020) Alessandro Bonardi et al. ACS Medicinal Chemistry Letters
- Carbonic Anhydrase Inhibitors Targeting Metabolism and Tumor Microenvironment
- (2020) Andrea Angeli et al. Metabolites
- RCSB Protein Data Bank: powerful new tools for exploring 3D structures of biological macromolecules for basic and applied research and education in fundamental biology, biomedicine, biotechnology, bioengineering and energy sciences
- (2020) Stephen K Burley et al. NUCLEIC ACIDS RESEARCH
- Editorial: Multi-Target-Directed Ligands (MTDL) as Challenging Research Tools in Drug Discovery: From Design to Pharmacological Evaluation
- (2019) Stefano Alcaro et al. Frontiers in Chemistry
- Selective COX-2 inhibitors as anticancer agents: a patent review (2014-2018)
- (2019) Sayyed Mohammad Ismail Mahboubi Rabbani et al. EXPERT OPINION ON THERAPEUTIC PATENTS
- Safer anti-inflammatory therapy through dual COX-2/5-LOX inhibitors: A structure-based approach
- (2018) Jaismy Jacob P et al. EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES
- The Acid–Base Balance and Gender in Inflammation: A Mini-Review
- (2018) Georges Jacques Casimir et al. Frontiers in Immunology
- Enhancement of the tail hydrophobic interactions within the carbonic anhydrase IX active site via structural extension: Design and synthesis of novel N-substituted isatins-SLC-0111 hybrids as carbonic anhydrase inhibitors and antitumor agents
- (2018) Wagdy M. Eldehna et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Highly Selective Cyclooxygenase-1 Inhibitors P6 and Mofezolac Counteract Inflammatory State both In Vitro and In Vivo Models of Neuroinflammation
- (2017) Rosa Calvello et al. Frontiers in Neurology
- Structural insight into the inhibition of carbonic anhydrase by the COX-2-selective inhibitor polmacoxib (CG100649)
- (2016) Hyun Tae Kim et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Acidosis differently modulates the inflammatory program in monocytes and macrophages
- (2016) Anne Riemann et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE
- Overexpression of the transmembrane carbonic anhydrase isoforms IX and XII in the inflamed synovium
- (2016) Francesca Margheri et al. JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY
- Isatin-pyrazole benzenesulfonamide hybrids potently inhibit tumor-associated carbonic anhydrase isoforms IX and XII
- (2015) Hany S. Ibrahim et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Efficient Expression and Crystallization System of Cancer-Associated Carbonic Anhydrase Isoform IX
- (2015) Janis Leitans et al. JOURNAL OF MEDICINAL CHEMISTRY
- Inflammation and cancer: advances and new agents
- (2015) Shanthini M. Crusz et al. Nature Reviews Clinical Oncology
- Selective Cyclooxygenase-1 Inhibition by P6 and Gastrotoxicity: Preliminary Investigation
- (2015) Maria Grazia Perrone et al. PHARMACOLOGY
- Multi-target approach for natural products in inflammation
- (2014) Andreas Koeberle et al. DRUG DISCOVERY TODAY
- Novel sulfonamides bearing pyrrole and pyrrolopyrimidine moieties as carbonic anhydrase inhibitors: Synthesis, cytotoxic activity and molecular modeling
- (2014) Mostafa M. Ghorab et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- 5-Lipoxygenase Antagonist therapy: a new approach towards targeted cancer chemotherapy
- (2013) K. Bishayee et al. ACTA BIOCHIMICA ET BIOPHYSICA SINICA
- Shifting from the single to the multitarget paradigm in drug discovery
- (2013) José L. Medina-Franco et al. DRUG DISCOVERY TODAY
- New selective carbonic anhydrase IX inhibitors: Synthesis and pharmacological evaluation of diarylpyrazole-benzenesulfonamides
- (2012) Tiphaine Rogez-Florent et al. BIOORGANIC & MEDICINAL CHEMISTRY
- Multiple Binding Modes of Inhibitors to Carbonic Anhydrases: How to Design Specific Drugs Targeting 15 Different Isoforms?
- (2012) Vincenzo Alterio et al. CHEMICAL REVIEWS
- Carbonic Anhydrases III and IV Autoantibodies in Rheumatoid Arthritis, Systemic Lupus Erythematosus, Diabetes, Hypertensive Renal Disease, and Heart Failure
- (2012) Chengeng Liu et al. Clinical & Developmental Immunology
- Novel selective COX-1 inhibitors suppress neuroinflammatory mediators in LPS-stimulated N13 microglial cells
- (2011) Rosa Calvello et al. PHARMACOLOGICAL RESEARCH
- Atomic resolution studies of carbonic anhydrase II
- (2010) Craig A. Behnke et al. ACTA CRYSTALLOGRAPHICA SECTION D-BIOLOGICAL CRYSTALLOGRAPHY
- The novel benzopyran class of selective cyclooxygenase-2 inhibitors. Part 2: The second clinical candidate having a shorter and favorable human half-life
- (2010) Jane L. Wang et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- COX-2's new role in inflammation
- (2010) Chu Chen Nature Chemical Biology
- Synthesis and Biological Evaluation of Novel Pyrazoles and Pyrazolo[3,4-d]pyrimidines Incorporating a Benzenesulfonamide Moiety
- (2009) Hayam M. A. Ashour et al. ARCHIV DER PHARMAZIE
- Carbonic anhydrases: novel therapeutic applications for inhibitors and activators
- (2008) Claudiu T. Supuran NATURE REVIEWS DRUG DISCOVERY
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started